These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 18375240

  • 1. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
    Taylor AJ.
    Am J Cardiol; 2008 Apr 17; 101(8A):36B-43B. PubMed ID: 18375240
    [Abstract] [Full Text] [Related]

  • 2. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ, Yellon DM.
    Heart; 2008 Jun 17; 94(6):706-14. PubMed ID: 18480348
    [Abstract] [Full Text] [Related]

  • 3. Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
    Brown BG, Zhao XQ.
    Am J Cardiol; 2008 Apr 17; 101(8A):58B-62B. PubMed ID: 18375243
    [Abstract] [Full Text] [Related]

  • 4. Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future?
    Kastelein JJ.
    Am J Cardiol; 2005 Nov 07; 96(9A):20K-27K; discussion 34K-35K. PubMed ID: 16291010
    [Abstract] [Full Text] [Related]

  • 5. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS.
    Angiology; 2009 Nov 07; 60(1):93-8. PubMed ID: 19019838
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
    Birjmohun RS, Hutten BA, Kastelein JJ, Stroes ES.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):185-97. PubMed ID: 15653014
    [Abstract] [Full Text] [Related]

  • 7. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA, Lavie CJ, Cardenas V, Milani RV, McCullough PA.
    Rev Cardiovasc Med; 2008 Jan 18; 9(4):239-58. PubMed ID: 19122582
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety of niacin and simvastatin combination therapy.
    Bays H.
    Am J Cardiol; 2008 Apr 17; 101(8A):3B-8B. PubMed ID: 18375239
    [Abstract] [Full Text] [Related]

  • 15. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
    Davidson M.
    Am J Cardiol; 2008 Dec 22; 102(12A):19L-27L. PubMed ID: 19084086
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M, Balcerak M, Chojnowska-Jezierska J.
    Pol Merkur Lekarski; 2007 Jan 22; 22(127):62-5. PubMed ID: 17477094
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lipid-altering therapies and the progression of atherosclerotic disease.
    Wierzbicki AS.
    Cardiovasc Intervent Radiol; 2007 Jan 22; 30(2):155-60. PubMed ID: 17206389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.